CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | ROCHE HOLDING LTD 10% owner | Conversion | +318,140 | 2,813,525 | ||
| 2021-11-02 | ROCHE HOLDING LTD 10% owner | Conversion · Series A Preferred Stock | −2,495,385 | 0 | ||
| 2021-11-02 | ROCHE HOLDING LTD 10% owner | Conversion · Series B Preferred Stock | −318,140 | 0 | ||
| 2021-11-02 | Redmile Group, LLC 10% owner | Conversion | +954,420 | 954,420 | ||
| 2021-11-02 | Redmile Group, LLC 10% owner | Purchase | +1,000,000 | $20.00 | $20.0M | 1,954,420 |
| 2021-11-02 | Redmile Group, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −954,420 | 0 | ||
| 2021-10-28 | Foley Todd Director | Grant or award · Stock Option (Right to Buy) | +23,552 | 23,552 | ||
| 2021-10-28 | PARMAR KUSH Director | Grant or award · Stock Option (Right to Buy) | +23,552 | 23,552 | ||
| 2021-10-28 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +72,012 | 72,012 | ||
| 2021-10-28 | Thistle Mary Director | Grant or award · Stock Option (Right to Buy) | +11,918 | 11,918 | ||
| 2021-10-28 | Sethuraman Natarajan Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +243,639 | 243,639 | ||
| 2021-10-28 | Nuechterlein Carole Director | Grant or award · Stock Option (Right to Buy) | +23,552 | 23,522 | ||
| 2021-10-28 | KREHER NERISSA Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +72,012 | 72,012 | ||
| 2021-10-28 | KIM PETER S Director | Grant or award · Stock Option (Right to Buy) | +11,918 | 11,918 | ||
| 2021-10-28 | Dowden Nathan J Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +95,148 | 95,148 | ||
| 2021-10-28 | Doshi Dipal President and CEO | Grant or award · Stock Option (Right to Buy) | +184,821 | 184,821 | ||
| 2021-10-28 | Crowley John F Director | Grant or award · Stock Option (Right to Buy) | +11,918 | 11,918 |
Page 29 of 29 · 577 trades